Modulatory Effects of NBF1, an Algal Fiber-Rich Bioformula, on Adiponectin and C-Reactive Protein Levels, and Its Therapeutic Prospects for Metabolic Syndrome and Type-2 Diabetes Patients.
Nlandu Roger NgatuMitsunori IkedaDaniel Kuezina TonduanguSeverin Luzitu NanganaTomohiro HiraoPublished in: Biomedicines (2022)
An unhealthy diet can lead to the development of metabolic disorders. C-reactive protein (CRP) has been reported to be an inflammatory component of metabolic disorders. Additionally, reduced adiponectin (APN) levels is known as a predictor of metabolic disorders. We report on the beneficial effects of NBF1, an algal fiber-rich formula, on CRP, APN, and diabetes markers. Additionally, associations between dietary nutrients, CRP, and APN were investigated. A dietary survey that used a brief self-administered diet history questionnaire, a validated 58-item fixed-portion-type questionnaire, and a 4-week placebo-controlled dietary intervention were carried out. The latter consisted of a twice daily intake of 3 g of sujiaonori alga-based powder as a supplement (NBF1, n = 16), whereas the placebo group received the same amount of corn starch powder ( n = 15). CRP and APN levels were assayed by ELISA. Clinical cases comprising three subjects with metabolic disorders treated with NBF1, including two type 2 diabetes mellitus patients and one subject with hypercholesterolemia, are also reported. They received 2.1g NBF1 once daily for 12 weeks. Intakes of algal fiber and n-3 PUFA were positively associated with the increase of APN, and n-3PUFA intake was inversely associated with CRP. All cases had improved metabolic health profile.
Keyphrases
- metabolic syndrome
- type diabetes
- end stage renal disease
- ejection fraction
- newly diagnosed
- physical activity
- randomized controlled trial
- glycemic control
- chronic kidney disease
- insulin resistance
- cardiovascular disease
- placebo controlled
- healthcare
- public health
- cross sectional
- peritoneal dialysis
- weight loss
- prognostic factors
- clinical trial
- mental health
- patient reported
- radiation therapy
- double blind
- study protocol
- climate change
- weight gain
- open label
- phase ii